BRÈVE

sur DIAGNOSTIC MEDICAL (EPA:ALDMS)

Strategic agreement between DMS Group, InnoLux and InnoCare

Graphique de l'évolution du cours de l'action DIAGNOSTIC MEDICAL (EPA:ALDMS).

DMS Group, a European medical imaging specialist, has signed an agreement in principle with InnoLux Corporation and its subsidiary InnoCare Optoelectronics. This commitment marks the beginning of a strategic partnership in the field of medical imaging. InnoLux, a major electronics company based in Taiwan, will invest up to €10 million, with an initial tranche of €2 million. The shares will be issued at €1.19, representing a 12% premium to the six-month average share price.

The goal of this partnership is to propel DMS Group as a leading European platform for medical imaging. Strengthening competitiveness through InnoLux technologies is a priority. However, the finalization of this agreement remains conditional, and the details of the next steps remain to be determined.

R. P.

Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.

Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève

Voir toutes les actualités de DIAGNOSTIC MEDICAL